Testing microbiota therapy for resistant bacteria in the gut
Part of Infections clinical trials.
This study tests a treatment made from healthy donor stool (called microbiota therapy) given as an enema or through a feeding tube. It aims to help people who carry resistant bacteria that are hard to treat, by reducing or clearing those bacteria from the gut.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal representative) must be able to understand and sign a consent form.
- You must be 18 years or older.
- You must have a stool or rectal swab that shows you carry a difficult-to-treat bacteria (like CRE, VRE, ESBL, or MDR Pseudomonas).
- You must be willing to stop antibiotics, probiotics, and other similar treatments 1 day before starting the study medicine and not restart until after day 28.
- Women who could become pregnant and men must agree to use effective birth control during the study, and women must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether an investigational treatment can help clear or reduce antibiotic-resistant bacteria living in the gut. It may help prevent these germs from causing future infections by targeting specific resistant bacteria found on stool or rectal swabs.
This trial tests whether a stool (fecal) transplant from a screened donor can help remove antibiotic-resistant gut bacteria (MDRO) that keep coming back in your stool tests. It aims to reduce colonization that makes follow-up and treatment harder.
This trial looks at a treatment made from stool donors (called fecal microbiome therapy) to help remove carbapenem-resistant gut bacteria in the body. It’s mainly for adults who recently tested positive for these bacteria on a rectal swab, and it checks whether the therapy can help eradicate the germs.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.
This trial tests three different ways to clear antibiotic-resistant bacteria from your gut using fecal microbiota transplant (FMT). It may help if you have a confirmed resistant infection and are looking for a treatment to reduce the risk of future infections.
Hear when a new Multi-Drug Resistant Organism Colonization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.